
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/">
  <dc:description xml:lang="eng">ABSTRACT
In order to enhance the risk stratification of papillary thyroid carcinoma (PTC) patients,
we assessed the presence of the most common mutation in PTC (BRAFV600E) with the expression profiles of long non-coding RNA activated by BRAFV600E (BANCR) and microRNAs, which share
complementarity with BANCR (miR-203a-3p and miR-204-3p), and thereafter correlated it with
several clinicopathological features of PTC. BRAFV600E was detected by mutant allele-specific PCR amplification. BANCR and miRs levels were determined by quantitative RT-PCR. Bioinformatic analysis was applied to determine the miRs’ targets. The expression profile of miR-203a-3p/204-3p in PTC was not affected by BRAFV600E. In the BRAFV600E-positive PTC, high expression of
miR-203a-3p correlated with extrathyroidal invasion (Ei), but the patients with both high miR-
203a-3p and upregulated BANCR were not at risk of Ei. In the BRAFV600E-negative PTC, low expression of miR-204-3p correlated with Ei, intraglandular dissemination and pT status (p &lt; 0.05), and the mutual presence of low miR-204-3p and upregulated BANCR increased the occurrence of Ei. Bioinformatic analysis predicted complementary binding between miR-203a-3p/204-3p and BANCR. The co-occurrence of tested factors might influence the spreading of PTC. These findings partially describe the complicated network of interactions that may occur during the development of PTC
aggressiveness, potentially providing a new approach for high-risk PTC patient selection.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:format>1417265 bytes</dc:format>
  <dc:subject xml:lang="eng">papillary thyroid carcinoma; long non-coding RNA; microRNAs; tumor markers; aggressiveness; prognosis</dc:subject>
  <dc:creator id="https://orcid.org/0000-0003-3808-0467">Stojanović, Stefana</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-2898-6671">Šelemetjev, Sonja</dc:creator>
  <dc:creator id="https://orcid.org/0000-0001-5322-4559">Đorić, Ilona</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-2589-3306">Janković Miljuš, Jelena</dc:creator>
  <dc:creator>Tatić, Svetislav</dc:creator>
  <dc:creator>Živaljević, Vladan</dc:creator>
  <dc:creator id="https://orcid.org/0000-0001-8475-2266">Išić Denčić, Tijana</dc:creator>
  <dc:source>Biomedicines 11(12)</dc:source>
  <dc:publisher>MDPI</dc:publisher>
  <dc:date>2023</dc:date>
  <dc:type>info:eu-repo/semantics/article</dc:type>
  <dc:language>eng</dc:language>
  <dc:rights>http://creativecommons.org/licenses/by/4.0/legalcode</dc:rights>
  <dc:title xml:lang="eng">BRAFV600E, BANCR, miR-203a-3p and miR-204-3p in Risk Stratification of PTC Patients</dc:title>
  <dc:identifier>https://phaidrabg.bg.ac.rs/o:32086</dc:identifier>
  <dc:identifier>doi:10.3390/biomedicines11123338</dc:identifier>
</oai_dc:dc>
